617 related articles for article (PubMed ID: 20028959)
1. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder.
Bendz LM; Scates AC
Ann Pharmacother; 2010 Jan; 44(1):185-91. PubMed ID: 20028959
[TBL] [Abstract][Full Text] [Related]
2. Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia.
Van Veen MM; Kooij JJ; Boonstra AM; Gordijn MC; Van Someren EJ
Biol Psychiatry; 2010 Jun; 67(11):1091-6. PubMed ID: 20163790
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia.
Hoebert M; van der Heijden KB; van Geijlswijk IM; Smits MG
J Pineal Res; 2009 Aug; 47(1):1-7. PubMed ID: 19486273
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder.
Van der Heijden KB; Smits MG; Van Someren EJ; Gunning WB
Chronobiol Int; 2005; 22(3):559-70. PubMed ID: 16076654
[TBL] [Abstract][Full Text] [Related]
5. [Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option?].
Holvoet E; Gabriëls L
Tijdschr Psychiatr; 2013; 55(5):349-57. PubMed ID: 23696337
[TBL] [Abstract][Full Text] [Related]
6. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB
J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627
[TBL] [Abstract][Full Text] [Related]
7. Sleep hygiene and actigraphically evaluated sleep characteristics in children with ADHD and chronic sleep onset insomnia.
van der Heijden KB; Smits MG; Gunning WB
J Sleep Res; 2006 Mar; 15(1):55-62. PubMed ID: 16490003
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
9. Use of modafinil for the treatment of attention deficit/hyperactivity disorder.
Lindsay SE; Gudelsky GA; Heaton PC
Ann Pharmacother; 2006 Oct; 40(10):1829-33. PubMed ID: 16954326
[TBL] [Abstract][Full Text] [Related]
10. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
12. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
14. Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.
Anand S; Tong H; Besag FMC; Chan EW; Cortese S; Wong ICK
Paediatr Drugs; 2017 Jun; 19(3):235-250. PubMed ID: 28391425
[TBL] [Abstract][Full Text] [Related]
15. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
Cohen-Zion M; Ancoli-Israel S
Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
[TBL] [Abstract][Full Text] [Related]
16. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
17. Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey.
Owens JA; Rosen CL; Mindell JA; Kirchner HL
Sleep Med; 2010 Aug; 11(7):692-700. PubMed ID: 20621556
[TBL] [Abstract][Full Text] [Related]
18. Management of chronic insomnia in elderly persons.
Bain KT
Am J Geriatr Pharmacother; 2006 Jun; 4(2):168-92. PubMed ID: 16860264
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of insomnia in children and adolescents: consensus statement.
Mindell JA; Emslie G; Blumer J; Genel M; Glaze D; Ivanenko A; Johnson K; Rosen C; Steinberg F; Roth T; Banas B
Pediatrics; 2006 Jun; 117(6):e1223-32. PubMed ID: 16740821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
